Hey, healthcare friends. Do you dread doing your notes every day? Do you feel like you can never get ahead of charting?

If you're shaking your head, yes, keep listening. Freed AI is a medical scribe on a mission to free clinicians everywhere.

Freed AI listens, transcribes, and writes medical documentation for you, written in your style,

and ready the moment the visit is over. All you have to do is give it to your patient. Just imagine

leaving the office at the same time as your last patient. Freed is HIPAA compliant, secure, and

takes less than 30 seconds to learn. Artificial intelligence

cannot replace you, but it can do the administrative work that no human should be subjected

to. Get back to doing what you love, helping your patients, and let freed AI do the rest.

Hey all, welcome back to the real life pharmacologyology podcast. I am your host, pharmacist, Eric

Christensen, and I thank you so much for listening today. As always, go check out that top 200 study

guide. It's a 31-page PDF, absolutely no cost to you. Simply an email will get you access to that.

So that's at real-life pharmacology.com.

All right, the drug of the day today is Lyna Glyptin.

Brand name of this medication is Tragenta.

This is classified as a DPP4 inhibitor.

It has anti-diabetic activity, thus lowering blood sugars.

And mechanistically, how it does that is it inhibits dipeptidase 4.

That's the DPP4, which is much easier to say. So this is an enzyme, and ultimately,

by inhibiting this enzyme, we prolong the action of incritin. And if you remember from

GLP1 agonus, incritin is an important hormone in kind of the homeostasis of glucose, blood sugar, and those type of things.

So those incritin hormones, GLP1, and GIP, so that's glucose-dependent, insulinotropic polypeptide.

These regulate that glucose homeostasis, thus increasing insulin synthesis is one of their roles,

...